Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01325987 · ClinicalTrials.gov registry record · NA

African American Children, Glycemic Control, and Type 2 Diabetes

A NA study of Type 2 Diabetes and Vitamin D Deficiency, sponsored by University of Alabama at Birmingham.

Completed
Registry status
NA
Development phase
31
Enrollment target
1
Study location

NCT01325987 is a NA study of Type 2 Diabetes and Vitamin D Deficiency that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 31 participants, below the 1,103-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01325987, a NA study of Type 2 Diabetes and Vitamin D Deficiency, has completed, sponsored by University of Alabama at Birmingham.

COMPLETED
Registry status
NA
Development phase
31 participants
Enrollment target
1
Study location

Study Summary

Using a randomized, placebo-controlled trial design in subjects with vitamin D deficiency, the investigators propose to determine if vitamin D treatment improves glycemic control in vitamin D deficient subjects with T2DM. The investigators hypothesize that oral vitamin D treatment will improve glycemic control and ß-cell function in vitamin D deficient AA subjects with T2DM. The investigators further hypothesize that maintaining serum 25(OH)D concentrations above 20 ng/ml with oral supplementation of vitamin D will have additional glycemic control effects.

Interventions

  • DIETARY_SUPPLEMENT Vitamin D2
  • OTHER Sugar pill

Study Locations (1)

Alabama

  • University of Alabama at Birmingham - Birmingham

Trial Details

FieldValue
Enrollment Target 31 participants
Start Date 2011-03
Est. Completion 2013-06
Phase NA

Sponsor

University of Alabama at Birmingham

1,160 total trials

What the Registry Record Tells You About NCT01325987

The ClinicalTrials.gov registry entry for NCT01325987 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,103-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (97% lower). The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Type 2 Diabetes appearing as the primary indexed condition, and to 2 interventions - of which Vitamin D2 is the first listed.

NCT01325987 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.

Frequently Asked Questions

What is clinical trial NCT01325987 about?

NCT01325987 is a clinical study titled "African American Children, Glycemic Control, and Type 2 Diabetes". Using a randomized, placebo-controlled trial design in subjects with vitamin D deficiency, the investigators propose to determine if vitamin D treatment improves glycemic control in vitamin D deficient subjects with T2DM. The investigators hypothesize that oral vitamin D treatment will improve glyce...

What is the current status of trial NCT01325987?

This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2011-03. Estimated completion is 2013-06.

What conditions does trial NCT01325987 study?

This clinical trial studies the following conditions: Type 2 Diabetes, Vitamin D Deficiency.

What interventions are being tested in trial NCT01325987?

The interventions under investigation include: Vitamin D2 (DIETARY_SUPPLEMENT), Sugar pill (OTHER).

Who is sponsoring clinical trial NCT01325987?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01325987 being conducted?

This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Type 2 Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.